Home > Healthcare > Medical Devices > Diagnostic Devices > ECG Stress Test Market

ECG Stress Test Market Size

  • Report ID: GMI5705
  • Published Date: May 2023
  • Report Format: PDF

ECG Stress Test Market Size

ECG Stress Test Market size was valued at around USD 2.3 billion in 2022 and is expected to grow at 8.1% CAGR from 2023 to 2032.The market revenue is estimated to reach over USD 5.2 billion in 2032 driven by Increasing awareness levels related to need of maintaining a healthy lifestyle and getting early diagnosis of different heart related diseases.

 

Additionally, the surge in digitization and automation of healthcare facilities along with integration of next-generation technologies to offer advanced and improved care to patients will complement the market expansion. Rise in healthcare expenditure, considerable growth in number of people suffering from various respiratory disorders, and increased instances of pulmonary illnesses such arrhythmia, among other factors are projected to contribute to market progress.

 

A stress test, also known as treadmill test or exercise test, is used to measure the health of the heart during physical activity. The test involves walking on a treadmill or a stationary bike that allows the healthcare professional to monitor patient's heart rhythm, breathing rate and blood pressure during the test through an ECG system. An ECG stress test can estimate if the person has any risk of having heart disease.

 

High cost of instruments used in ECG stress test and lack of experienced staff performing the test especially in underdeveloped countries is anticipated to impede the market share. For instance, the stress test machines can cost in the range of USD 4,000 to USD 9,000. Healthcare facilities with limited capital budgets find it difficult to deploy such systems. Moreover, the cost of stress tests for uninsured patients can go up to around USD 5,000.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for ECG stress test was around USD 2.3 billion in 2022 and will reach over USD 5.2 billion in 2032.

Exercise testing systems segment share was over 49% in 2022 attributed to the ability of exercise testing systems to assess integrative exercise responses including the pulmonary, cognitive, hematopoietic, circulatory, and skeletal muscle systems.

North America region held the leading revenue share in the global market and is expected to reach over USD 1.6 billion in 2032 attributed to the rising awareness pertaining to early detection of heart and lungs related disorders.

Koninklijke Philips NV, Nihon Kohden Corp, General Electric Co., Vyaire Medical Inc., COSMED Srl, Biosensors International Group Ltd., and SCHILLER AG among others.

ECG Stress Test Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 17
  • Tables & Figures: 194
  • Countries covered: 30
  • Pages: 150
 Download Free Sample